Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Cash Flows

v3.7.0.1
Condensed Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Cash Flows from Operating Activities:    
Net loss $ (10,831) $ (9,010)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 3,361 1,891
Issuance of common shares - Founders Agreement 0 14
Amortization of debt discount 0 324
Research and development-licenses acquired, expensed 400 2,060
Changes in operating assets and liabilities:    
Prepaid expenses and other assets (803) 167
Other receivables - related party (22) (1,184)
Accounts payable and accrued expenses 434 1,850
Net cash used in operating activities (7,461) (3,888)
Cash Flows from Investing Activities:    
Purchase of research and development licenses (400) (2,060)
Net cash used in investing activities (400) (2,060)
Cash Flows from Financing Activities:    
Payment of note payable 0 (2,792)
Proceeds from issuance of common stock 0 570
Net cash used in financing activities 0 (2,222)
Net decrease in cash (7,861) (8,170)
Cash at beginning of period 35,086 50,418
Cash at end of period 27,225 42,248
Supplemental disclosure of cash flow information:    
Cash paid for interest 0 20
Supplemental disclosure of noncash investing and financing activities:    
Issuance of common shares - Founders Agreement $ 3,919 $ 3,024